Find uplifting stories about heroes, innovations, and solutions
10765 results for "non-drug treatment"
Moffitt Cancer Center researchers discovered that scheduling treatment breaks between cancer drug doses may help keep therapies working longer by slowing drug resistance. The breakthrough combines math and biology to extend the lifespan of targeted cancer treatments.
Researchers at Baylor College of Medicine created an experimental drug that weakens multiple cancer survival mechanisms at once, potentially solving one of medicine's toughest challenges. Early results show it helps resistant tumors respond to treatment again.
A common asthma medication could help hard-to-treat cancers like triple-negative breast cancer respond to immunotherapy. Scientists discovered the drug reverses immune cells that tumors hijack to resist treatment.
A simpler HIV treatment just earned FDA approval, giving doctors a new option for patients managing the virus alongside other health conditions. The once-daily pill combines two drugs instead of three, offering hope for people juggling multiple medications.
An experimental pill for multiple sclerosis outperformed an approved drug in two major trials, giving 2,000 patients new hope for fewer relapses. The developer plans to seek global approval for the treatment.
New research suggests GLP-1 medications may help treat alcohol, opioid, and drug addictions by quieting cravings in the brain. A study of 600,000 veterans found fewer ER visits and deaths across all substance types.
%252c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Scientists at MD Anderson Cancer Center discovered an experimental therapy that stops aggressive leukemia cells even after they've become resistant to standard treatments. The breakthrough could help patients with the deadliest forms of blood cancer who have run out of options.
Patients in England with advanced gastrointestinal stromal tumors now have a fourth treatment option after NHS approved ripretinib, a drug that extends life with fewer side effects. For those who've exhausted all other therapies and faced weeks to live, this approval brings genuine hope.
A revolutionary pain treatment discovered at Stony Brook University just secured $11 million to help cancer patients suffering from nerve damage without the risk of addiction. The therapy targets pain in a completely new way, offering hope to millions who currently have no FDA-approved options.
Scientists have discovered why drugs like Ozempic reduce cravings for alcohol, nicotine, and other addictive substances. The breakthrough reveals a hidden control center in the brain that manages how we think about rewards.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A groundbreaking pain medication that doesn't rely on opioids or traditional painkillers just cleared a major hurdle with Canadian health regulators. If approved, suzetrigine would be the first new class of acute pain treatment available in Canada in 20 years.
University of Michigan scientists discovered a breakthrough treatment combination that stops prostate cancer cells from escaping hormone therapy by changing their identity. The two-drug approach slowed tumor growth significantly in lab studies and could transform treatment for thousands of men facing aggressive, treatment-resistant disease.
A groundbreaking cancer treatment just showed remarkable results that exceeded doctors' expectations in treating one of the deadliest forms of lung cancer. The drug ivonescimab reduced the risk of death by 34% compared to standard treatment for patients with squamous non-small cell lung cancer.
Japanese researchers have captured the first real-time footage of lung cancer drugs physically reshaping disease-causing proteins, revealing why some treatments eventually stop working. The breakthrough could help doctors design better therapies that overcome drug resistance.
University of Michigan researchers discovered that combining two existing drugs significantly slowed the growth of treatment-resistant prostate cancer in lab and animal studies. The breakthrough offers new hope for men with aggressive forms of the disease that no longer respond to standard treatments.
Millions of Medicare patients will soon pay less for cancer treatments, HIV medications, and other essential drugs after 15 new medicines were selected for federal price negotiations. The new list includes the first physician-administered treatments ever chosen for these cost-cutting talks.
A treatment for a rare bacterial lung infection just proved it can help patients much sooner than before. The drug, already approved for advanced cases, now shows real benefits when given to newly diagnosed patients.
A new experimental drug from biotech company Roivant just achieved remarkable results in treating a serious form of pulmonary hypertension, opening doors to better treatments for patients struggling with this dangerous lung condition. The Phase 2 study showed the drug significantly improved blood flow, breathing ability, and heart health markers.
A groundbreaking drug designed to treat endometriosis without hormones or surgery just got FDA approval to begin human trials. For 190 million women worldwide living with this painful, overlooked condition, it's a ray of hope after decades of limited options.
Showing 20 of 10765